Equities

Beamtree Holdings Ltd

BMT:ASX

Beamtree Holdings Ltd

Actions
Health CareHealth Care Providers
  • Price (AUD)0.2875
  • Today's Change0.003 / 0.88%
  • Shares traded67.50k
  • 1 Year change+10.58%
  • Beta1.7497
Data delayed at least 20 minutes, as of Sep 20 2024 06:55 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 19-Sep-24
Select bar for recommendation details.
Recommendations19-Sep-24
Buy0
Outperform2
Hold0
Sell0
Strong Sell0

Share price forecast in AUD

The 2 analysts offering 12 month price targets for Beamtree Holdings Ltd have a median target of 0.590, with a high estimate of 0.70 and a low estimate of 0.48. The median estimate represents a 105.22% increase from the last price of 0.2875.
High143.5%0.70
Med105.2%0.590
Low67.0%0.48

Earnings history & estimates in AUD

Beamtree Holdings Ltd reported annual 2024 losses of -0.018 per share on Aug 26, 2024.
Average growth rate-632.14%
More ▼

Revenue history & estimates in AUD

PKS Holdings Limited had revenues for the full year 2024 of 27.60m. This was 21.23% above the prior year's results.
Average growth rate+64.86%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.